MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20103637

February 19, 2021

国药准字H20103637

Drug Information

瑞格列奈片

孚来迪

孚来迪

片剂

1.0mg

化学药品

February 19, 2021

Company Information

Applicant Company

江苏省连云港经济技术开发区

Manufacturing Company

连云港经济技术开发区东晋路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath